Scott Van Wier
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 15
- Multiple Myeloma Research and Treatments 15
-
- Protein Degradation and Inhibitors 6
- Glycosylation and Glycoproteins Research 3
- Co-authors
- Rafaël Fonseca (24 shared papers)P. Leif Bergsagel (12 shared papers)Esteban Braggio (16 shared papers)A. Keith Stewart (4 shared papers)Jonathan J. Keats (10 shared papers)Marta Chesi (7 shared papers)Victoria M. Garbitt (2 shared papers)Chang-Xin Shi (2 shared papers)
- Journals
- Blood (15 papers)Leukemia (3 papers)Clinical Cancer Research (1 paper)Neuro-Oncology (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesSingaporeMalaysia
In The Last Decade
Scott Van Wier
23 papers receiving 1.4k citations
Scott Van Wier's Hit Papers
Peers
Comparison fields: 5 of 61
- Hematology 888
- Genetics 189
- Oncology 376
- Pathology and Forensic Medicine 236
- Molecular Biology 898
Countries citing papers authored by Scott Van Wier
This map shows the geographic impact of Scott Van Wier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Van Wier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Van Wier more than expected).
Fields of papers citing papers by Scott Van Wier
This network shows the impact of papers produced by Scott Van Wier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Van Wier. The network helps show where Scott Van Wier may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Van Wier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide Hit paper breakdown → | 2011 | 465 |
| 2 | Clonal competition with alternating dominance in multiple myeloma Hit paper breakdown → | 2012 | 457 |
| 3 | 2014 | 185 | |
| 4 | 2015 | 152 | |
| 5 | 2013 | 49 | |
| 6 | 2010 | 37 | |
| 7 | 2010 | 27 | |
| 8 | 2009 | 18 | |
| 9 | 2014 | 15 | |
| 10 | 2008 | 3 | |
| 11 | 2005 | 3 | |
| 12 | 2012 | 2 | |
| 13 | 2008 | 1 | |
| 14 | 2006 | 1 | |
| 15 | 2006 | 1 | |
| 16 | 2011 | 1 | |
| 17 | 2016 | 1 | |
| 18 | 2010 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2013 | 1 |
About Scott Van Wier
Scott Van Wier is a scholar working on Hematology, Molecular Biology, Genetics, Pathology and Forensic Medicine and Neurology, having authored 24 papers that have together received 1.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (15 papers), Protein Degradation and Inhibitors (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (4 papers), Glycosylation and Glycoproteins Research (3 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), Genomic variations and chromosomal abnormalities (3 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Hematology (888 citations), Genetics (189 citations), Oncology (376 citations), Pathology and Forensic Medicine (236 citations) and Molecular Biology (898 citations). Scott Van Wier has collaborated with scholars based in United States, Singapore and Malaysia. Frequent co-authors include Rafaël Fonseca, P. Leif Bergsagel, Esteban Braggio, A. Keith Stewart, Jonathan J. Keats, Marta Chesi, Victoria M. Garbitt, Chang-Xin Shi, Jessica Schmidt and Laura A. Bruins. Their work appears in journals such as Blood, Leukemia, Clinical Cancer Research, Neuro-Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.